Quotes 5-day view End-of-day quote Tokyo Stock Exchange
10/23/2020
10/26/2020
10/27/2020
10/28/2020
10/29/2020
Date
2606
2619
2623
2671
2651
Last
471000
345500
504300
620100
833200
Volume
-0.72% +0.50% +0.15% +1.83% -0.75% Change
Sales 2020
322 B 3 073 M 3 073 M
Net income 2020
48 219 M 461 M 461 M
Net cash position 2020
191 B 1 829 M 1 829 M
P/E ratio 2020
29,6x
Yield 2020
1,66%
Sales 2021
351 B 3 358 M 3 358 M
Net income 2021
58 190 M 556 M 556 M
Net cash position 2021
224 B 2 136 M 2 136 M
P/E ratio 2021
24,7x
Yield 2021
1,79%
Capitalization
1 424 B 13 651 M 13 605 M
EV / Sales 2020
3,83x
EV / Sales 2021
3,42x
Nbr of Employees
5 267
Free-Float
45,8%
Kyowa Kirin Co., Ltd. (formerly Kyowa Hakko Kirin Co., Ltd.) specializes in the development, manufacturing and marketing of pharmaceutical and biochemical products. Net sales break down by source of revenue as follows:
- sales of pharmaceutical products (94.1%): prescription products for anemia, cancers, immune and nephrology diseases treatment;
- sales of licenses (5.9%).
At the end of 2019, the group had 3...
Notations Surperformance© of Kyowa Kirin Co., Ltd.
Trading Rating : Investor Rating :
All news about KYOWA KIRIN CO., LTD.
News in other languages on KYOWA KIRIN CO., LTD.
Chart KYOWA KIRIN CO., LTD.
Duration :
Auto.
2 months
3 months
6 months
9 months
1 year
2 years
5 years
10 years
Max.
Period :
Day
Week
Technical analysis trends KYOWA KIRIN CO., LTD.
Short Term Mid-Term Long Term Trends Bearish Neutral Bullish
Income Statement Evolution
Please enable JavaScript in your browser's settings to use dynamic charts.
Mean consensus
BUY
Number of Analysts
11
Average target price
3 374,00 JPY
Last Close Price
2 651,00 JPY
Spread / Highest target
58,4%
Spread / Average Target
27,3%
Spread / Lowest Target
5,24%
Please enable JavaScript in your browser's settings to use dynamic charts.
Canada
Deutschland
France
Schweiz (DE)
United Kingdom
Report
